SHR‐1703, a novel long‐acting anti‐interleukin‐5 monoclonal antibody, in asthma patients: A randomized, double‐blind, placebo‐controlled phase 1 study
Authors
- Meng Fu (ORCID: https://orcid.org/0009-0006-1687-9816)
- Yajun Zhang (ORCID: https://orcid.org/0000-0002-1182-6057)
- Lixiu He (ORCID: https://orcid.org/0000-0001-7193-1791)
- Zhu Luo
- Xiaotong Li
- Ling Yang
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Jiangsu Hengrui Medicine (China) (CN)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1002/bcp.70439
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00